Oral Oncology
Volume 46, Issue 5 , Pages 355-359 , May 2010

Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA–BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch

  • Romina F. Aromando

      Affiliations

    • Department of Oral Pathology, Faculty of Dentistry, University of Buenos Aires, Argentina
    • Department of Radiobiology, National Atomic Energy Commission, Constituyentes Atomic Center, Argentina
    • Corresponding Author InformationCorresponding author. Address: Department of Oral Pathology, Faculty of Dentistry, University of Buenos Aires, Argentina. Tel.: +54 11 4964 1273; fax: +54 11 6772 7188.
    • ,
  • Verónica A. Trivillin

      Affiliations

    • Department of Radiobiology, National Atomic Energy Commission, Constituyentes Atomic Center, Argentina
    • ,
  • Elisa M. Heber

      Affiliations

    • Department of Radiobiology, National Atomic Energy Commission, Constituyentes Atomic Center, Argentina
    • ,
  • Emiliano Pozzi

      Affiliations

    • Department of Radiobiology, National Atomic Energy Commission, Constituyentes Atomic Center, Argentina
    • Research and Production Reactors, National Atomic Energy Comission, Ezeiza Atomic Center, Argentina
    • ,
  • Amanda E. Schwint

      Affiliations

    • Department of Radiobiology, National Atomic Energy Commission, Constituyentes Atomic Center, Argentina
    • ,
  • María E. Itoiz

      Affiliations

    • Department of Oral Pathology, Faculty of Dentistry, University of Buenos Aires, Argentina
    • Department of Radiobiology, National Atomic Energy Commission, Constituyentes Atomic Center, Argentina

Received 14 January 2010 ,Revised 11 February 2010 ,Accepted 12 February 2010.

References 

  1. Locher GL. Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol. 1936;36:1–13
  2. Taylor HJ, Goldhaber M. Detection of nuclear disintegration in a photographic emulsion. Nature (London). 1935;135:341–348
  3. Gabel D, Fairchild RG, Larsson B. The relative biological effectiveness in V79 Chinese hamster cells of the neutron capture reaction in boron and nitrogen. Radiat Res. 1984;98:307–316
  4. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res. 1999;151(1):1–18
  5. Coderre JA, Chanana AD, Joel DD, Elowitz EH, Micca PL, Nawrocky MM, et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res. 1998;149:163–170
  6. Aihara T, Hiratsuka J, Morita N, Uno M, Sakurai Y, Maruhashi A, et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. Head Neck. 2006;28(9):850–855
  7. Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res. 2005;11(11):3987–4002
  8. Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, et al. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenyalanine (BPA). Radiother Oncol. 2008;88:183–191
  9. Wittig A, Sauerwein WA, Coderre JA. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiat Res. 2000;153:173–180
  10. Heber EM, Trivillin VA, Nigg DW, Itoiz ME, Gonzalez BN, Rebagliati RJ, et al. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model. Arch Oral Biol. 2006;51:922–929
  11. Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot. 2004;61:1069–1073
  12. Henriksson R, Capala J, Michanek A, Lindahl S, Salford L, Franzen L, et al. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Radiother Oncol. 2008;88:183–191
  13. Yamamoto T, Nakai T, Matsumura A. Boron neutron capture therapy for glioblastoma. Cancer Lett. 2008;262:143–152
  14. González SJ, Bonomi MR, Santa Cruz GA, Blaumann HR, Calzetta Larrieu OA, Menéndez P, et al. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl Radiat Isot. 2004;61:1101–1105
  15. Kreimann EL, Itoiz ME, Longhino J, Blaumann H, Calzetta O, Schwint AE. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res (Adv Brief). 2001;61:8638–8642
  16. Kreimann EL, Itoiz ME, Dagrosa A, Garavaglia R, Farías S, Batistoni D, et al. The hamster cheek pouch model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer Res. 2001;61:8775–8781
  17. Kreimann EL, Miura M, Itoiz ME, Heber EM, Garavaglia RN, Batistoni D, et al. Biodistribution of a carborane-containing porphyrin as a targeting agent for boron neutron capture therapy of oral cancer in the hamster cheek pouch. Arch Oral Biol. 2003;48:223–232
  18. Heber EM, Trivillin VA, Nigg DW, Kreimann E, Itoiz ME, Rebagliati RJ, et al. Biodistribution of GB-10 (Na210B10H10) compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch. Arch Oral Biol. 2004;49:313–324
  19. Heber EM, Aromando RF, Trivillin VA, Itoiz ME, Nigg DW, Kreimann EL, et al. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model. Arch Oral Biol. 2007;52:273–279
  20. Trivillin VA, Heber EM, Itoiz ME, Nigg DW, Calzetta O, Blaumann H, et al. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer. Appl Radiat Isot. 2004;61:939–945
  21. Trivillin VA, Heber EM, Nigg DW, Itoiz ME, Calzetta O, Blaumann H, et al. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat Res. 2006;166:387–396
  22. Aromando RF, Heber EM, Trivillin VA, Nigg DW, Schwint AE, Itoiz ME. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model. J Oral Pathol Med. 2009;38(5):448–454
  23. Heber EM, Monti Hugges A, Pozzi ECC, Itoiz ME, Aromando RF, Molinari AJ, et al. Development of a model of tissue with potentially malignant disorders (PMD) in the hamster cheek pouch to explore the long-term potential therapeutic and/or toxic effects of different therapeutic modalities. Arch Oral Biol. 2010;55(1):46–51
  24. Salley JJ. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res. 1954;33:253–262
  25. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282–3287
  26. Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol. 2004;5(12):708
  27. Petersen PE. Tobacco and oral health. The role of the world health organization. Oral Health Prev Dent. 2003;1(4):309–315
  28. Petersen PE. Oral cancer prevention and control – the approach of the World Health Organization. Oral Oncol. 2009;45(4–5):454–460
  29. Pozzi E, Nigg DW, Miller M, Thorp SI, Heber EM, Zarza L, et al. Dosimetry and radiobiology at the RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer. Appl Radiat Isot. 2009;61:939–945
  30. Yoshii M, Jikuhara A, Mori S, Iwagaki H, Takahashi H, Nishibori M, et al. Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin and MAP kinase-dependent manners. J Pharmacol Sci. 2005;98:450–458
  31. Aromando RF, Pérez MA, Heber EM, Trivillin VA, Tomasi VH, Schwint AE, et al. Potential role of mast cells in hamster cheek pouch carcinogenesis. Oral Oncol. 2008;44:1080–1087
  32. LaHann TR, Lu DR, Daniell G, Kraft SL, Gavin PR, Bauer WF. Bioavailability of intravenous formulations of p-boronophenylalanine in dog and rat. In:  Soloway A,  Barth R,  Carpenter D editor. Advances in neutron capture therapy. New York: Plenum Press; 1993;p. 585–589
  33. Enerbäck L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand. 1966;66(3):303–312
  34. Enerbäck L. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand. 1966;66(3):289–302
  35. Mayrhofer G. Fixation and staining of granules in mucosal mast cells and intraepithelial lymphocytes in the rat jejunum with specimen reference to the relationship between the acid glycosaminoglycans in the two cell types. Histochem J. 1989;12:513–526
  36. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura matter mast cells. Neuroscience. 1991;44:97–112
  37. Kanakura Y, Thompson H, Yamamura T, Asai H, Kitamura Y, Metcalfe DD, et al. Multiple bi-directional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells. Blood. 1988;72(3):877–885
  38. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol. 1989;7:59–76
  39. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CMM, Tsai M. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749–786
  40. Cabrini RL, Itoiz ME, Carranza FA, Mayo J, Smolko EE. Histological and histochemical analysis of the effect on oral tissues and tooth germs of irradiation with deuteron beams. Helv Odont Acta. 1967;11:124–130
  41. Albrecht M, Müller K, Köhn FM, Meineke V, Mayerhofer A. Ionizing radiation induces degranulation of human mast cells and release of tryptase. Int J Radiat Biol. 2007;83(8):535–541
  42. Vasheghani MM, Bayat M, Rezaei A, Karimipour M. Effect of low level laser therapy on mast cells in second-degree burns in rats. Photomed Laser Surg. 2008;26(1):1–5
  43. Jikuhara A, Yoshii M, Iwagaki H, Mori S, Nishibori M, Tanaka N. MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. Life Sci. 2003;73(22):2817–2829
  44. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70

PII: S1368-8375(10)00054-0

doi: 10.1016/j.oraloncology.2010.02.007

Oral Oncology
Volume 46, Issue 5 , Pages 355-359 , May 2010

Article Tools

* Image Usage & Resolution